Constraints and challenges in convalescent plasma collection amidst the Covid 19 pandemic- strategies and recommendations to overcome these

BACKGROUND: COVID 19 is an acute respiratory disease caused by infection by the virus SARS-COV-2 and has been declared as a pandemic whose specific treatment is still not established. One of the options in the treatment is Convalescent plasma (CP) therapy when there is presence of required amount of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahapatra, S., Pati, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931723/
https://www.ncbi.nlm.nih.gov/pubmed/33677086
http://dx.doi.org/10.1016/j.tracli.2021.02.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931723/
https://www.ncbi.nlm.nih.gov/pubmed/33677086
http://dx.doi.org/10.1016/j.tracli.2021.02.003

Ejemplares similares